{"result": {"id": "chatcmpl-278", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **patients** in the study were individuals affected by various conditions, including NANFH, asymptomatic carotid plaque, diabetes, unilateral treatment-naïve exudative neovascular age-related macular degeneration (nAMD), and those with CF-LVADs.  They also included individuals diagnosed with AMD and those experiencing corneal neovascularization, lipid keratopathy, or proliferative retinopathy. The study focused on **patients** who had ischemic strokes, received anti-VEGF injections, and showed varying responses to treatment. Some of the **patients** were specifically those with SC hemoglobinopathy and CCRC, while others were consecutive patients studied for their response to IVIs.  \n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743328756, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 137, "prompt_tokens": 293, "total_tokens": 430, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"PATIENTS\"\nDescription List: [\"23 patients with HM and mCNV received IVIs\", \"Consecutive patients were studied\", \"Individuals who have had an ischemic stroke\", \"Individuals with SC hemoglobinopathy and proliferative retinopathy\", \"Individuals with corneal neovascularization and lipid keratopathy\", \"Patients are those affected by the condition of NANFH\", \"Patients in the study\", \"Patients who received anti-VEGF injections and showed varying responses\", \"Patients with CCRC\", \"Patients with asymptomatic carotid plaque\", \"Patients with diabetes\", \"Patients with unilateral treatment-naïve exudative neovascular age-related macular degeneration (nAMD)\", \"People who have CF-LVADs\", \"People who have been diagnosed with AMD\", \"People with choroidal neovascularization\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_43e7ac87808c5ad22339bd19701626f128f5274a4d167b5927f7774bcd254752_v2"}